233 related articles for article (PubMed ID: 38316520)
21. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
Ghiorzo P; Pastorino L; Queirolo P; Bruno W; Tibiletti MG; Nasti S; Andreotti V; ; Paillerets BB; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2013 Mar; 26(2):259-62. PubMed ID: 23167872
[TBL] [Abstract][Full Text] [Related]
22. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β.
Pierrat MJ; Marsaud V; Mauviel A; Javelaud D
J Biol Chem; 2012 May; 287(22):17996-8004. PubMed ID: 22496449
[TBL] [Abstract][Full Text] [Related]
23. MITF E318K: A rare homozygous case with multiple primary melanoma.
Wallingford CK; Maas EJ; Howard A; DeBortoli E; Bhanja D; Lee K; Mothershaw A; Jagirdar K; Willett R; Betz-Stablein B; Sturm RA; Soyer HP; McInerney-Leo AM
Pigment Cell Melanoma Res; 2024 Jan; 37(1):68-73. PubMed ID: 37635363
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study.
Gromowski T; Masojć B; Scott RJ; Cybulski C; Górski B; Kluźniak W; Paszkowska-Szczur K; Rozmiarek A; Dębniak B; Maleszka R; Kładny J; Lubiński J; Dębniak T
Cancer Genet; 2014 Apr; 207(4):128-32. PubMed ID: 24767713
[TBL] [Abstract][Full Text] [Related]
26. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
27. The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma.
Castro-Vega LJ; Kiando SR; Burnichon N; Buffet A; Amar L; Simian C; Berdelou A; Galan P; Schlumberger M; Bouatia-Naji N; Favier J; Bressac-de Paillerets B; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4764-4768. PubMed ID: 27680874
[TBL] [Abstract][Full Text] [Related]
28. MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.
Berwick M; MacArthur J; Orlow I; Kanetsky P; Begg CB; Luo L; Reiner A; Sharma A; Armstrong BK; Kricker A; Cust AE; Marrett LD; Gruber SB; Anton-Culver H; Zanetti R; Rosso S; Gallagher RP; Dwyer T; Venn A; Busam K; From L; White K; Thomas NE;
Pigment Cell Melanoma Res; 2014 May; 27(3):485-8. PubMed ID: 24406078
[TBL] [Abstract][Full Text] [Related]
29. PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
Maskin CR; Raman R; Houvras Y
Sci Rep; 2022 Apr; 12(1):5573. PubMed ID: 35368039
[TBL] [Abstract][Full Text] [Related]
30. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
[TBL] [Abstract][Full Text] [Related]
32. Frequent mutations in the MITF pathway in melanoma.
Cronin JC; Wunderlich J; Loftus SK; Prickett TD; Wei X; Ridd K; Vemula S; Burrell AS; Agrawal NS; Lin JC; Banister CE; Buckhaults P; Rosenberg SA; Bastian BC; Pavan WJ; Samuels Y
Pigment Cell Melanoma Res; 2009 Aug; 22(4):435-44. PubMed ID: 19422606
[TBL] [Abstract][Full Text] [Related]
33. Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
Lauss M; Haq R; Cirenajwis H; Phung B; Harbst K; Staaf J; Rosengren F; Holm K; Aine M; Jirström K; Borg Å; Busch C; Geisler J; Lønning PE; Ringnér M; Howlin J; Fisher DE; Jönsson G
J Invest Dermatol; 2015 Jul; 135(7):1820-1828. PubMed ID: 25705847
[TBL] [Abstract][Full Text] [Related]
34. Acetylation reprograms MITF target selectivity and residence time.
Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
[TBL] [Abstract][Full Text] [Related]
35. Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair.
Seoane M; Buhs S; Iglesias P; Strauss J; Puller AC; Müller J; Gerull H; Feldhaus S; Alawi M; Brandner JM; Eggert D; Du J; Thomale J; Wild PJ; Zimmermann M; Sternsdorf T; Schumacher U; Nollau P; Fisher DE; Horstmann MA
Oncogene; 2019 May; 38(19):3616-3635. PubMed ID: 30651597
[TBL] [Abstract][Full Text] [Related]
36. MITF: master regulator of melanocyte development and melanoma oncogene.
Levy C; Khaled M; Fisher DE
Trends Mol Med; 2006 Sep; 12(9):406-14. PubMed ID: 16899407
[TBL] [Abstract][Full Text] [Related]
37. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.
Nordlinger A; Dror S; Elkahloun A; Del Rio J; Stubbs E; Golan T; Malcov H; Pricket TD; Cronin JC; Parikh S; Labes S; Thomas L; Yankovitz G; Tabach Y; Levy C; Samuels Y; Khaled M
J Invest Dermatol; 2018 Oct; 138(10):2216-2223. PubMed ID: 29679610
[TBL] [Abstract][Full Text] [Related]
38. Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1.
Anacker DC; Gautam D; Gillespie KA; Chappell WH; Moody CA
J Virol; 2014 Aug; 88(15):8528-44. PubMed ID: 24850735
[TBL] [Abstract][Full Text] [Related]
39. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
[TBL] [Abstract][Full Text] [Related]
40. BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export.
Ngeow KC; Friedrichsen HJ; Li L; Zeng Z; Andrews S; Volpon L; Brunsdon H; Berridge G; Picaud S; Fischer R; Lisle R; Knapp S; Filippakopoulos P; Knowles H; Steingrímsson E; Borden KLB; Patton EE; Goding CR
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8668-E8677. PubMed ID: 30150413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]